In contrast, CD4+Foxp3+ T cells, known as regulatory T cells (Tregs), which can hamper effective antitumor immunity, were significantly decreased in the tumor tissue of the ES-DSM + MW treated group (Fig. 7b and Supplementary Fig. 18c). Here, CD4 is linked to neoplasm.